2004
DOI: 10.1016/j.jtcvs.2004.03.036
|View full text |Cite
|
Sign up to set email alerts
|

Tracheobronchial amyloidosis: A surgical disease with long-term consequences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(11 citation statements)
references
References 4 publications
0
10
0
Order By: Relevance
“…3) Amyloidosis, which is characterized by extracellular deposits of amyloid material, can occur with chronic inflammatory diseases (e.g., rheumatoid arthritis, Crohn's disease, and tuberculosis). 4) Spencer classified pulmonary amyloidosis into 3 categories: tracheobronchial amyloidosis (Type-1), nodular parenchymal amyloidosis (Type-2), and diffuse parenchymal (interstitial/diffuse alveolar septal) amyloidosis (Type-3). 5) According to the Spencer classification of pulmonary amyloidosis, the present case was classified as Type-2 pulmonary amyloidosis.…”
Section: Discussionmentioning
confidence: 99%
“…3) Amyloidosis, which is characterized by extracellular deposits of amyloid material, can occur with chronic inflammatory diseases (e.g., rheumatoid arthritis, Crohn's disease, and tuberculosis). 4) Spencer classified pulmonary amyloidosis into 3 categories: tracheobronchial amyloidosis (Type-1), nodular parenchymal amyloidosis (Type-2), and diffuse parenchymal (interstitial/diffuse alveolar septal) amyloidosis (Type-3). 5) According to the Spencer classification of pulmonary amyloidosis, the present case was classified as Type-2 pulmonary amyloidosis.…”
Section: Discussionmentioning
confidence: 99%
“…The long-term effect of this treatment on the tracheobronchial amyloidosis is entirely unknown, and the patient must continue to be monitored. (4) Lobectomy: Lobectomy had been described in the literature for treatment of pulmonary amyloidosis in severe cases with extensive airway involvement [29], even though they are rarely performed.…”
Section: Discussionmentioning
confidence: 99%
“…It affects males more than females. The median onset age is 50 -60 years old with ranging from age 27 to 85 years [4,5]. Common symptoms include dyspnea, nonproductive cough, haemoptysis and hoarseness [6].…”
Section: Discussionmentioning
confidence: 99%